|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.670 USD | -.--% |
|
-.--% | - |
| 08/10/25 | MannKind Corporation completed the acquisition of scPharmaceuticals Inc.. | CI |
| 08/10/25 | MannKind Completes Acquisition of scPharmaceuticals | MT |
| Market Cap | 305M 267M 246M 231M 433M 28.76B 441M 2.96B 1.15B 14.21B 1.14B 1.12B 49.28B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 281M 246M 227M 213M 398M 26.49B 407M 2.73B 1.06B 13.09B 1.05B 1.03B 45.4B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
98.42% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: scPharmaceuticals Inc.
| 1 year | 3.77 |  | 6.28 |
| 3 years | 1.94 | | 10.59 |
| 5 years | 1.94 | | 12.75 |
| 10 years | 1.94 | | 18.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 49 | 07/10/2025 |
| Director of Finance/CFO | 50 | 07/10/2025 | |
David Thomson
SEC | Corporate Secretary | 59 | 07/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Castagna
BRD | Director/Board Member | 49 | 07/10/2025 |
David Thomson
BRD | Director/Board Member | 59 | 07/10/2025 |
| Director/Board Member | 50 | 07/10/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/10/25 | Tender | Chief Executive Officer | 1,571,021 | 3.1395% | ||
| 07/10/25 | Tender | Chief Financial Officer | 363,707 | 0.7268% | ||
| 07/10/25 | Tender | Director | 177,950 | 0.3556% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +46.51% | -44.74% | 305M | |
| +7.13% | +9.97% | +55.80% | +163.38% | 1,077B | |
| +3.99% | +11.50% | +67.09% | +56.27% | 613B | |
| +4.20% | +17.03% | +38.97% | +91.19% | 448B | |
| +0.31% | +4.85% | +28.17% | +22.04% | 332B | |
| -0.50% | +6.85% | +40.32% | +26.38% | 293B | |
| -0.89% | +4.02% | +30.10% | +40.38% | 286B | |
| -1.90% | +4.05% | -29.00% | -41.49% | 215B | |
| +1.56% | +6.14% | +29.30% | +61.91% | 193B | |
| +3.26% | +3.33% | +15.55% | +67.87% | 159B | |
| Average | +1.72% | +7.63% | +32.28% | +44.32% | 361.64B | |
| Weighted average by Cap. | +3.35% | +9.65% | +41.58% | +80.67% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
163
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SCPH Stock
Select your edition
All financial news and data tailored to specific country editions
